Edinburgh Study Spots 95% Endometriosis Signal in Blood, Challenging Surgery-Based Diagnosis
Updated
Updated · BBC.com · Jul 7
Edinburgh Study Spots 95% Endometriosis Signal in Blood, Challenging Surgery-Based Diagnosis
3 articles · Updated · BBC.com · Jul 7
Summary
A University of Edinburgh-led study found a blood-based hormone fingerprint that correctly identified more than 95% of endometriosis patients, pointing to a potential alternative to surgical diagnosis.
The result came from blood tests on 159 women with confirmed endometriosis and 57 without it, with researchers detecting distinct androgen patterns — including higher levels of some hormones — in affected patients.
That matters because endometriosis affects 1 in 10 women in the UK and diagnosis in Scotland takes more than 10 years on average, according to Endometriosis UK.
Researchers said the approach still needs larger, more diverse trials and testing against other hormone-imbalance conditions before it could become a reliable clinical test.
The team is seeking industry partners to develop the technology, while advocates say a validated non-surgical test could cut diagnosis times to months and support earlier treatment.
As multiple AI-driven blood tests emerge, who will win the race to end years of diagnostic delays for patients?
Beyond just diagnosis, can this new blood test predict disease severity and guide personalized patient care?
If endometriosis is linked to 'male hormones,' have we been treating this women's health crisis all wrong?
Edinburgh Scientists Unveil Blood Test Identifying 95% of Endometriosis Cases, Paving Way for Early, Non-Invasive Diagnosis
Overview
University of Edinburgh scientists and their partners have made a major breakthrough by discovering findings that could lead to a simple blood test for endometriosis. This new approach promises a much faster and less invasive alternative to current methods, which often require years of waiting and invasive surgery like laparoscopy. If successfully developed and validated, the blood test could dramatically reduce diagnosis times and spare many people from the prolonged suffering caused by delayed diagnosis. This advancement has the potential to fundamentally change how endometriosis is detected and improve the lives of those affected.